This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Greenberg, R N Articles by Saeed, A M Search for Related Content PubMed PubMed Citation Articles by Greenberg, R N Articles by Saeed, A M

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1987 February; 31(2): 151-155

Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin.

R N Greenberg, D J Kennedy, P M Reilly, K L Luppen, W J Weinandt, M R Bollinger, F Aguirre, F Kodesch and A M Saeed

ABSTRACT

We treated 52 patients with orally administered ciprofloxacin. In this study of 34 men and 18 women who completed therapy and who could be evaluated, there were 29 patients with nonhematogenous osteomyelitis, 20 patients with skin or soft-tissue infections, and 3 patients with joint infections. During the study, 92 isolates of pathogenic facultative aerobic bacteria, including 37 members of the family Enterobacteriaceae, 30 Staphylococcus aureus isolates, and 21 Pseudomonas aeruginosa isolates, were recovered, and 88 (96%) of the isolates were found to be susceptible to ciprofloxacin. Of the 29 patients with osteomyelitis, 14 have not experienced relapse after a follow-up of at least 1 year. Overall, 61% of infections were resolved, as judged by both clinical and microbiological criteria, during therapy. One patient developed Streptococcus salivarius sepsis during ciprofloxacin therapy, and one patient developed a rash which required discontinuation of ciprofloxacin. Otherwise, there were no serious reactions or complications.

---

Antimicrob Agents Chemother. 1987 February; 31(2): 151-155

This article has been cited by other articles:

• Landersdorfer, C. B., Kinzig, M., Hennig, F. F., Bulitta, J. B., Holzgrabe, U., Drusano, G. L., Sorgel, F., Gusinde, J. (2009). Penetration of Moxifloxacin into Bone Evaluated by Monte Carlo Simulation. Antimicrob. Agents Chemother. 53: 2074-2081 [Abstract] [Full Text]  
• Sanchez-Recio, M. M., Colino, C.-I., Sanchez-Navarro, A. (2000). A retrospective analysis of pharmacokinetic/pharmacodynamic indices as indicators of the clinical efficacy of ciprofloxacin. J Antimicrob Chemother 45: 321-328 [Abstract] [Full Text]  
• Greenberg, R. N., Newman, M. T., Shariaty, S., Pectol, R. W. (2000). Ciprofloxacin, Lomefloxacin, or Levofloxacin as Treatment for Chronic Osteomyelitis. Antimicrob. Agents Chemother. 44: 164-166 [Abstract] [Full Text]  
• Chambers, H. F., Xiang, Q., Liu, , Chow, L. L., Hackbarth, C. (1999). Efficacy of Levofloxacin for Experimental Aortic-Valve Endocarditis in Rabbits Infected with Viridans Group Streptococcus or Staphylococcus aureus. Antimicrob. Agents Chemother. 43: 2742-2746 [Abstract] [Full Text]  
• Joshi, N., Milfred, D. (1995). The Use and Misuse of New Antibiotics: A Perspective. Arch Intern Med 155: 569-577 [Abstract]  
• Blumberg, H. M. (1991). Oral Quinolone Treatment for Osteomyelitis. ANN INTERN MED 115: 832-832 [Abstract]  
• Newman, L. G., Waller, J., Palestro, C. J., Schwartz, M., Klein, M. J., Hermann, G., Harrington, E., Harrington, M., Roman, S. H., Stagnaro-Green, A. (1991). Unsuspected Osteomyelitis in Diabetic Foot Ulcers: Diagnosis and Monitoring by Leukocyte Scanning With Indium In 111 Oxyquinoline. JAMA 266: 1246-1251 [Abstract]  
• Wilkes, L., Fish, D., Danziger, L. H. (1991). Treatment of Skin and Soft Tissue Infections. Journal of Pharmacy Practice 4: 192-203